Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -7.98% | -19.35% | -79.59% |
Evolution of the average Target Price on Immuneering Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Immuneering Corporation
Mizuho Securities | |
Jefferies & Co. | |
Needham & Co. | |
Chardan Research | |
TD Cowen | |
Guggenheim | |
Morgan Stanley | |
Oppenheimer | |
Piper Sandler | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- IMRX Stock
- Consensus Immuneering Corporation